← Back to Search

Radiation Therapy

CyberKnife Stereotactic Radiosurgery for Non-Small Cell Lung Cancer

Phase 2
Waitlist Available
Research Sponsored by Accuray Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

This trial will study the effectiveness of CyberKnife radiosurgery for early stage NSCLC in patients who are not healthy enough for surgery.

Eligible Conditions
  • Non-Small Cell Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Local progression-free survival, local disease progression, clinical response rate, regional recurrence-free survival, distant recurrence-free survival.
Secondary outcome measures
To characterize and compare quality of life before and after stereotactic radiosurgery treatment. To assess procedure-related outcomes after stereotactic radiosurgery of lung tumors.

Trial Design

1Treatment groups
Experimental Treatment
Group I: CyberKnife Stereotactic RadiosurgeryExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CyberKnife Stereotactic Radiosurgery
2007
N/A
~380

Find a Location

Who is running the clinical trial?

Accuray IncorporatedLead Sponsor
9 Previous Clinical Trials
841 Total Patients Enrolled
University of PittsburghOTHER
1,729 Previous Clinical Trials
16,307,450 Total Patients Enrolled
James Luketich, MDStudy ChairUniversity of Pittsburgh Medical Center
2 Previous Clinical Trials
212 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer
2006. "CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00643318.
All > Lung > Sclc
~2 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top